CID 3749

Irbesartan

Structural Information

Molecular Formula
C25H28N6O
SMILES
CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
InChI
InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)
InChIKey
YOSHYTLCDANDAN-UHFFFAOYSA-N
Compound name
2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
Related CIDs

2D Structure

compound 2d structure
9
Annotation Hits

2078
References

45308
Patents

428.23245 Da
Monoisotopic Mass

4.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 429.23973 202.6
[M+Na]+ 451.22167 209.4
[M-H]- 427.22517 209.6
[M+NH4]+ 446.26627 210.4
[M+K]+ 467.19561 201.5
[M+H-H2O]+ 411.22971 189.3
[M+HCOO]- 473.23065 216.2
[M+CH3COO]- 487.24630 209.6
[M+Na-2H]- 449.20712 197.1
[M]+ 428.23190 200.6
[M]- 428.23300 200.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe